©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

The Art of Drug Choice: Wet AMD and the Latest Data [Miniseries]

Office-Based Temporary Scleral Buckle
Office-Based Temporary Scleral Buckle

Joseph Asilis, MD, Nikolas J.S. London, MD, Paul E. Tornambe, MD, FACS

A Breakthrough After Monthly Wet AMD Therapy
A Breakthrough After Monthly Wet AMD Therapy

Nikolas J.S. London, MD

Take-Home Points From the BOULEVARD Trial
Take-Home Points From the BOULEVARD Trial

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

New Horizons for Treatment Options for DR
New Horizons for Treatment Options for DR

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

How to Manage Patient Buy-In for Anti-VEGF Therapy
How to Manage Patient Buy-In for Anti-VEGF Therapy

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Anti-VEGF Therapy for Patients With Proliferative and Nonproliferative Disease
Anti-VEGF Therapy for Patients With Proliferative and Nonproliferative Disease

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Widefield Imaging
Widefield Imaging

Nikolas J.S. London, MD, Szilard Kiss, MD

Intraoperative OCT
Intraoperative OCT

Justis Ehlers, MD, Nikolas J.S. London, MD

MEAD: Diabetic Macular Edema Trial Subanalysis
MEAD: Diabetic Macular Edema Trial Subanalysis

Nikolas J.S. London, MD, Anat Lowenstein, MD

Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment
Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment

Nikolas J.S. London, MD, Rahul Khurana, MD

Evaluation of Intraocular Inflammation and Pain Post Intravitreal Injection of Ranibizumab or Aflibercept: The PLANET Study
Evaluation of Intraocular Inflammation and Pain Post Intravitreal Injection of Ranibizumab or Aflibercept: The PLANET Study

Arshad M. Khanani, MD, Nikolas J.S. London, MD

Optical Coherence Tomography Measurement of Retinal Pigment Epithelium Drusen Complex Predicts 2-Year Progression of Age-Related Macular Degeneration
Optical Coherence Tomography Measurement of Retinal Pigment Epithelium Drusen Complex Predicts 2-Year Progression of Age-Related Macular Degeneration

Nikolas J.S. London, MD, Sumit Sharma, MD

Long-Term Treatment Outcomes for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen
Long-Term Treatment Outcomes for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen

Carl Regillo, MD, Nikolas J.S. London, MD

Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy
Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy

David Lally, MD, Nikolas J.S. London, MD

Key Outcomes of SAKURA 1: A Phase 3 Study of Intravitreal Sirolimus for Noninfectious Posterior Segment Uveitis
Key Outcomes of SAKURA 1: A Phase 3 Study of Intravitreal Sirolimus for Noninfectious Posterior Segment Uveitis

Nikolas J.S. London, MD, Quan Dong Nguyen, MD

iDEAL Phase 2 Study of Intravitreal iCo-007 for Diabetic Macular Edema
iDEAL Phase 2 Study of Intravitreal iCo-007 for Diabetic Macular Edema

Nikolas J.S. London, MD, Quan Dong Nguyen, MD

The Art of Drug Choice: Wet AMD and the Latest Data

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

ASRS ’23: Missed Injections for AMD/DME/RVO and Anatomic Response to Vabysmo in Wet AMD

Christina Y. Weng, MD, MBA; and Nikolas JS London, MD

The Art of Drug Choice: Phase 3 Trials in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

The Art of Drug Choice: Wet AMD Pipeline

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA